COCRYSTAL PHARMA, INC. Interest Expense Nonoperating
COCRYSTAL PHARMA, INC. (COCP) reported Interest Expense Nonoperating of -$10.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-13
- COCRYSTAL PHARMA, INC. interest expense nonoperating for the quarter ending 2026-06-30 was -$10.00K.
- COCRYSTAL PHARMA, INC. interest expense nonoperating for the quarter ending 2026-03-31 was -$22.00K.
- COCRYSTAL PHARMA, INC. interest expense nonoperating for the quarter ending 2025-12-31 was -$47.00K.
- COCRYSTAL PHARMA, INC. interest expense nonoperating for the quarter ending 2025-09-30 was -$22.00K.
- COCRYSTAL PHARMA, INC. interest expense nonoperating for fiscal 2025 was -$134.00K.
- COCRYSTAL PHARMA, INC. interest expense nonoperating for fiscal 2024 was -$537.00K.
- COCRYSTAL PHARMA, INC. interest expense nonoperating for fiscal 2023 was -$640.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$10.00K 10-Q · filed 2026-08-13 | -$32.00K 10-Q · filed 2026-08-13 | -$79.00K derived: sum of 3 quarters · filed 2026-08-13 | -$101.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$22.00K 10-Q · filed 2026-05-15 | -$69.00K derived: sum of 2 quarters · filed 2026-05-15 | -$91.00K derived: sum of 3 quarters · filed 2026-05-15 | -$119.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$69.00K derived: sum of 2 quarters · filed 2026-03-31 | -$97.00K derived: sum of 3 quarters · filed 2026-08-13 | -$134.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$22.00K 10-Q · filed 2025-11-14 | -$50.00K derived: sum of 2 quarters · filed 2026-08-13 | -$87.00K 10-Q · filed 2025-11-14 | -$142.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$28.00K 10-Q · filed 2026-08-13 | -$65.00K 10-Q · filed 2026-08-13 | -$120.00K derived: sum of 3 quarters · filed 2026-08-13 | -$231.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$37.00K 10-Q · filed 2026-05-15 | -$92.00K derived: sum of 2 quarters · filed 2026-05-15 | -$203.00K derived: sum of 3 quarters · filed 2026-05-15 | -$354.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$166.00K derived: sum of 2 quarters · filed 2026-03-31 | -$317.00K derived: sum of 3 quarters · filed 2026-03-31 | -$537.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$111.00K 10-Q · filed 2025-11-14 | -$262.00K derived: sum of 2 quarters · filed 2025-11-14 | -$482.00K 10-Q · filed 2025-11-14 | -$662.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$151.00K 10-Q · filed 2025-08-14 | -$371.00K 10-Q · filed 2025-08-14 | -$551.00K derived: sum of 3 quarters · filed 2025-08-14 | -$871.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$220.00K 10-Q · filed 2025-05-15 | -$400.00K derived: sum of 2 quarters · filed 2025-05-15 | -$720.00K derived: sum of 3 quarters · filed 2025-05-15 | -$860.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$500.00K derived: sum of 2 quarters · filed 2025-03-31 | -$640.00K derived: sum of 3 quarters · filed 2025-03-31 | -$640.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$320.00K 10-Q · filed 2024-11-13 | -$460.00K derived: sum of 2 quarters · filed 2024-11-13 | -$460.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | -$140.00K 10-Q · filed 2024-08-14 | -$140.00K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |